Search research articles
Contact Us
Filters
Showing results (701-710 of 981) with videos related to
Page
of 99
Sort By:
Diabetes
|
November 7, 2022
Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes
Elaine Chow, Ke Wang, Cadmon K P Lim, et al.
The Lancet Regional Health. Western Pacific
|
October 13, 2025
Trends of lipid-lowering drug utilization, treatment intensity and LDL-C target attainment in adults with diabetes and non-dialysis chronic kidney disease in Hong Kong
Yanting Huang, Aimin Yang, Mai Shi, et al.
Age and Ageing
|
October 9, 2025
A novel electronic-health-record based, machine-learning model to predict 1-year risk of fall hospitalisation in older adults: a Hong Kong territory-wide cohort and modelling study
Aimin Yang, Mai Shi, Eric S H Lau, et al.
Diabetes Research and Clinical Practice
|
October 15, 2023
Comparison of beta-cell function between Hong Kong Chinese with young-onset type 2 diabetes and late-onset type 2 diabetes
Yingnan Fan, Baoqi Fan, Eric S H Lau, et al.
Diabetes Care
|
September 24, 2008
Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry
Xilin Yang, Gary T C Ko, Wing Yee So, et al.
BMC Medicine
|
June 3, 2014
Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
Alice P S Kong, Xilin Yang, Wing-Yee So, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 22, 2024
Health outcomes after national acute sleep deprivation events among the American public
Neil J Kelly, Rahul Chaudhary, Wadih El Khoury, et al.
Diabetes, Obesity & Metabolism
|
April 16, 2011
A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes
A P S Kong, A Yamasaki, R Ozaki, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 12, 2010
Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and beta-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes--an 8-year prospective cohort analysis of 1297 patients
Y Wang, A O Y Luk, R C W Ma, et al.
Diabetes, Obesity & Metabolism
|
September 9, 2022
Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register
Lee-Ling Lim, Eric S H Lau, Johnny T K Cheung, et al.
Page
of 99
Search research articles
Search
Showing results (701-710 of 981) with videos related to
Sort By:
Page
of 99
Diabetes
|
November 7, 2022
Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes
Elaine Chow, Ke Wang, Cadmon K P Lim, et al.
The Lancet Regional Health. Western Pacific
|
October 13, 2025
Trends of lipid-lowering drug utilization, treatment intensity and LDL-C target attainment in adults with diabetes and non-dialysis chronic kidney disease in Hong Kong
Yanting Huang, Aimin Yang, Mai Shi, et al.
Age and Ageing
|
October 9, 2025
A novel electronic-health-record based, machine-learning model to predict 1-year risk of fall hospitalisation in older adults: a Hong Kong territory-wide cohort and modelling study
Aimin Yang, Mai Shi, Eric S H Lau, et al.
Diabetes Research and Clinical Practice
|
October 15, 2023
Comparison of beta-cell function between Hong Kong Chinese with young-onset type 2 diabetes and late-onset type 2 diabetes
Yingnan Fan, Baoqi Fan, Eric S H Lau, et al.
Diabetes Care
|
September 24, 2008
Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry
Xilin Yang, Gary T C Ko, Wing Yee So, et al.
BMC Medicine
|
June 3, 2014
Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
Alice P S Kong, Xilin Yang, Wing-Yee So, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 22, 2024
Health outcomes after national acute sleep deprivation events among the American public
Neil J Kelly, Rahul Chaudhary, Wadih El Khoury, et al.
Diabetes, Obesity & Metabolism
|
April 16, 2011
A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes
A P S Kong, A Yamasaki, R Ozaki, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 12, 2010
Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and beta-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes--an 8-year prospective cohort analysis of 1297 patients
Y Wang, A O Y Luk, R C W Ma, et al.
Diabetes, Obesity & Metabolism
|
September 9, 2022
Real-world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register
Lee-Ling Lim, Eric S H Lau, Johnny T K Cheung, et al.
Page
of 99